Sanofi SA (NYSE:SNY)

42.07
Delayed Data
As of Jul 18
 +0.13 / +0.31%
Today’s Change
37.43
Today|||52-Week Range
50.65
-2.16%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$96.2B

Company Description

Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities. This segment also includes all associates whose activities are related to pharmaceuticals. The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for its Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines. The company was founded on April 28, 1994 and is headquartered in Paris, France.

Contact Information

Sanofi
54, rue La Boétie
Paris Ile-de-france 75008
P:(315) 377-4000
Investor Relations:

Employees

Shareholders

Mutual fund holders4.39%
Other institutional4.10%
Individual stakeholders--

Top Executives

Olivier BrandicourtChief Executive Officer & Director
Jérôme ContamineChief Financial Officer & Executive VP-Finance
Ameet NathwaniExecutive Vice President-Medical Affairs
John C. ReedHead-Global Research & Development
Dominique CarougeExecutive VP & Head-Business Transformation